pharmaceutical investing Acerus Updates on Temporary Unavailability of NATESTO in Canada and South Korea
pharmaceutical investing VIDEO - Acerus Pharma CEO: Keeping Focus on Drug Delivery Tech, Not Cannabis
Acerus Receives Notice of Deficiency – Withdrawal Letter from Health Canada Regarding Gynoflor Application
pharmaceutical investing Acerus Announces Results of Phase 1 Clinical Trial with a Proprietary Intranasal Formulation of a Tetrahydrocannabinol-Rich Cannabis Oil
pharmaceutical investing Acerus Provides Update on Continuing Commercial and R&D Achievements for NATESTO®
pharmaceutical investing Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe
Cerrado Gold Acquires the Past-Producing Manantial Espejo Mine in Santa Cruz, Argentina, from Pan American Silver
Triumph Gold Announces Strategic Review of Non-Core Exploration Projects and $15 Million Private Placement